John Stephen Fox
Président chez PHion Therapeutics Ltd.
Profil
John Stephen Fox was the founder of Hunter-Fleming Ltd.
founded in 1999 where he held the title of Planning Director.
He is currently the Non-Executive Chairman of PHion Therapeutics Ltd., Chairman of Ferryx Ltd., Director of Transcriptogen Ltd., Director of Greenlight Pharmaceuticals Ltd., Member of The Royal Society of Medicine, and Member of Drug Information Association.
Dr. Fox's former positions include Chairman of Endocrine Pharmaceuticals Ltd., Non-Executive Director of Southampton Asset Management Ltd., Planning Director of Shire Pharmaceuticals, Inc., Chief Development Officer of Merrion Pharmaceuticals Plc in 2014, and Principal of Eli Lilly & Co. Ltd.
Dr. Fox received his undergraduate and doctorate degrees from Queen's University and his MBA from Henley Management College.
Postes actifs de John Stephen Fox
| Sociétés | Poste | Début |
|---|---|---|
The Royal Society of Medicine
 The Royal Society of Medicine Miscellaneous Commercial ServicesCommercial Services The Royal Society of Medicine provides postgraduate medical education. The Society provides a range of educational activities and opportunities for doctors, dentists and veterinary surgeons, including students, and for allied healthcare professionals. It also promotes an exchange of information and ideas on the science, practice and organization of medicine, both within the health professions and with responsible and informed public opinion. The Society was founded in 1805 and is headquartered in London, the United Kingdom. | Corporate Officer/Principal | 11/08/2011 |
Drug Information Association
 Drug Information Association Miscellaneous Commercial ServicesCommercial Services The Drug Information Association is a non-profit multidisciplinary association that operates to promote health and well-being. The non-profit company is based in Horsham, PA. Marwan Fathallah has been the CEO of the company since 2023. | Corporate Officer/Principal | 11/08/2011 |
PHion Therapeutics Ltd.
 PHion Therapeutics Ltd. BiotechnologyHealth Technology PHion Therapeutics Ltd. operates as a therapeutic vaccine development company. Its vaccine program focuses on viral infections as it evokes a strong interferon gamma response. The firm's technology are RAVA and RAVA-V. The company was founded by Helen McCarthy in 2017 and is headquartered in Belfast, the United Kingdom. | Président | - |
Greenlight Pharmaceuticals Ltd.
 Greenlight Pharmaceuticals Ltd. Pharmaceuticals: OtherHealth Technology Greenlight Pharmaceuticals Ltd. engages in the development of plant-based medicines. It focuses in phytocannabinoid research. The company was founded by James Linden in 2014 and is headquartered in Dublin Ireland. | Directeur/Membre du Conseil | - |
Transcriptogen Ltd.
 Transcriptogen Ltd. BiotechnologyHealth Technology Transcriptogen Ltd. operates as a drug discovery company to exploit the use of small molecules to inhibit the interaction of transcription factors (TFs) with their cognate DNA-recognition site, thus down-regulating or inhibiting the transcription of disease-related genes. The firm develops and discovers anti-cancer drugs. The company was founded by Khondaker Miraz Rahman, Paul Jackson, and Sheraz Gul and is headquartered in Bath, the United Kingdom. | Directeur/Membre du Conseil | 01/01/2017 |
Ferryx Ltd.
 Ferryx Ltd. BiotechnologyHealth Technology Ferryx Ltd. develops safe and effective bacterial products for the treatment and prevention of gut inflammation. The company is based in Bristol, UK. The British company was founded in 2019 by Jenny Bailey and Tristan Cogan. Jenny Bailey has been the CEO since 2019. | Président | - |
Anciens postes connus de John Stephen Fox
| Sociétés | Poste | Fin |
|---|---|---|
Southampton Asset Management Ltd.
 Southampton Asset Management Ltd. Investment ManagersFinance Southampton Asset Management Ltd (SAM) is a venture capital firm, a subsidiary of University of Southampton Holdings Ltd. The firm is headquartered in Southampton, United Kingdom. | Directeur/Membre du Conseil | - |
Hunter-Fleming Ltd.
 Hunter-Fleming Ltd. Pharmaceuticals: MajorHealth Technology Hunter-Fleming Ltd. dvelops pharmaceutical products. The company was founded by James R. Murray, John S. Fox and Ernst Wülfert in February 1999 and is headquartered in Brixham, the United Kingdom. | Fondateur | - |
Endocrine Pharmaceuticals Ltd.
 Endocrine Pharmaceuticals Ltd. Miscellaneous Commercial ServicesCommercial Services Endocrine Pharmaceuticals Ltd. engages in the development of hormonal drugs. If focuses on the research of micrin a naturally occurring mammalian hormonal inhibitor of tissue masses and cellular integrity. The company is headquartered in Tadley, the United Kingdom. | Président | - |
| ░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░ ░░░░░░░░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░ | - |
Formation de John Stephen Fox
| Queen's University | Doctorate Degree |
| Henley Management College | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 12 |
|---|---|
Merrion Pharmaceuticals Plc
 Merrion Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Merrion Pharmaceuticals Plc engages in the development of oral forms of drugs which have suboptimal absorption. It also invests in companies focusing in the healthcare sector. The company was founded by Michael Mary Donnelly in December 2003 and is headquartered in Dublin, Ireland. | Health Technology |
Southampton Asset Management Ltd.
Southampton Asset Management Ltd. Investment ManagersFinance Southampton Asset Management Ltd (SAM) is a venture capital firm, a subsidiary of University of Southampton Holdings Ltd. The firm is headquartered in Southampton, United Kingdom. | Finance |
Hunter-Fleming Ltd.
Hunter-Fleming Ltd. Pharmaceuticals: MajorHealth Technology Hunter-Fleming Ltd. dvelops pharmaceutical products. The company was founded by James R. Murray, John S. Fox and Ernst Wülfert in February 1999 and is headquartered in Brixham, the United Kingdom. | Health Technology |
Endocrine Pharmaceuticals Ltd.
Endocrine Pharmaceuticals Ltd. Miscellaneous Commercial ServicesCommercial Services Endocrine Pharmaceuticals Ltd. engages in the development of hormonal drugs. If focuses on the research of micrin a naturally occurring mammalian hormonal inhibitor of tissue masses and cellular integrity. The company is headquartered in Tadley, the United Kingdom. | Commercial Services |
Eli Lilly & Co. Ltd.
 Eli Lilly & Co. Ltd. Pharmaceuticals: MajorHealth Technology Eli Lilly & Co. Ltd. provides pharmaceutical health care solutions. It provide products for cardiovascular, dermatology, diabetes, endocrine, musculoskeletal, neuroscience, oncology and urology. The company was incorporated on April 9, 1963 and is headquartered in Basingstoke, the United Kingdom. | Health Technology |
The Royal Society of Medicine
The Royal Society of Medicine Miscellaneous Commercial ServicesCommercial Services The Royal Society of Medicine provides postgraduate medical education. The Society provides a range of educational activities and opportunities for doctors, dentists and veterinary surgeons, including students, and for allied healthcare professionals. It also promotes an exchange of information and ideas on the science, practice and organization of medicine, both within the health professions and with responsible and informed public opinion. The Society was founded in 1805 and is headquartered in London, the United Kingdom. | Commercial Services |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Health Technology |
Drug Information Association
Drug Information Association Miscellaneous Commercial ServicesCommercial Services The Drug Information Association is a non-profit multidisciplinary association that operates to promote health and well-being. The non-profit company is based in Horsham, PA. Marwan Fathallah has been the CEO of the company since 2023. | Commercial Services |
Transcriptogen Ltd.
Transcriptogen Ltd. BiotechnologyHealth Technology Transcriptogen Ltd. operates as a drug discovery company to exploit the use of small molecules to inhibit the interaction of transcription factors (TFs) with their cognate DNA-recognition site, thus down-regulating or inhibiting the transcription of disease-related genes. The firm develops and discovers anti-cancer drugs. The company was founded by Khondaker Miraz Rahman, Paul Jackson, and Sheraz Gul and is headquartered in Bath, the United Kingdom. | Health Technology |
Greenlight Pharmaceuticals Ltd.
Greenlight Pharmaceuticals Ltd. Pharmaceuticals: OtherHealth Technology Greenlight Pharmaceuticals Ltd. engages in the development of plant-based medicines. It focuses in phytocannabinoid research. The company was founded by James Linden in 2014 and is headquartered in Dublin Ireland. | Health Technology |
PHion Therapeutics Ltd.
PHion Therapeutics Ltd. BiotechnologyHealth Technology PHion Therapeutics Ltd. operates as a therapeutic vaccine development company. Its vaccine program focuses on viral infections as it evokes a strong interferon gamma response. The firm's technology are RAVA and RAVA-V. The company was founded by Helen McCarthy in 2017 and is headquartered in Belfast, the United Kingdom. | Health Technology |
Ferryx Ltd.
Ferryx Ltd. BiotechnologyHealth Technology Ferryx Ltd. develops safe and effective bacterial products for the treatment and prevention of gut inflammation. The company is based in Bristol, UK. The British company was founded in 2019 by Jenny Bailey and Tristan Cogan. Jenny Bailey has been the CEO since 2019. | Health Technology |